Abstract:Highlights • Identifying the XO inhibitory inhibition of crude extract and fractions. • Eighteen potential XO compounds were isolated and elucidated. • Six XO inhibitors from D. spathacea were identified. • The potency XO inhibitors interact with active site and molybdopterin center of XO. Xanthine oxidase (XO) has been widely recognized as a pivotal enzyme in developing hyperuricemia, primarily contributing to the excessive production of uric acid during purine metabolism in the liver. One of the standard treatment approaches involves reducing uric acid levels by inhibiting XO activity. In this study, the leaf extract of Dolichandrone spathacea , traditionally used in folk medicine, was found to inhibit XO activity in the ethyl acetate and butanol fractions at a concentration of 100 μg/mL, their values were 78.57 ± 3.85 % (IC 50 = 55.93 ± 5.73 μg/ml) and 69.43 ± 8.68 % (IC 50 = 70.17 ± 7.98 μg/ml), respectively. The potential XO inhibitory components were isolated by bioactivity assays and the HR-ESI-MS and NMR spectra system. The main constituents of leaf extracts of Dolichandrone spathacea , six compounds, namely trans- 4-methoxycinnamic acid ( 3 ), trans -3,4-dimethoxycinnamic acid ( 4 ), p -coumaric acid ( 5 ), martynoside ( 6 ), 6-O-( p -methoxy- E -cinnamoyl)-ajugol ( 7 ), and scolymoside ( 17 ), were identified as potent XO inhibitors with IC 50 values ranging from 19.34 ± 1.63 μM to 64.50 ± 0.94 μM. The enzyme kinetics indicated that compounds 3 – 5 , 7 , and 17 displayed competitive inhibition like allopurinol, while compound 6 displayed a mixed-type inhibition. Computational studies corroborated these experimental results, highlighting the interactions between potential metabolites and XO enzyme. The hydrogen bonds played crucial roles in the binding interaction, especially, scolymoside ( 17 ) forms a hydrogen bond with Mos3004, exhibited the lowest binding energy (−18.3286 kcal/mol) corresponding to the lowest IC 50 (19.34 ± 1.63 μM). Furthermore, nine compounds were isolated for the first time from this plant. In conclusion , Dolichandrone spathacea and its constituents possess the potential to modulate the xanthine oxidase enzyme involved in metabolism.

Inhibition of Xanthine Oxidase by Liquiritigenin and Isoliquiritigenin Isolated from Sinofranchetia Chinensis

Characterization of the global metabolic profile of liquiritin in rat plasma, urine, bile and feces based on UHPLC-FT-ICR MS

Inhibition of Xanthine Oxidase by Some Chinese Medicinal Plants Used to Treat Gout

Xanthine oxidase inhibitors from Brandisia hancei

Isoliquiritigenin, A Natural Anti-Oxidant, Selectively Inhibits the Proliferation of Prostate Cancer Cells

The inhibitory kinetics and mechanism of quercetin-3-O-rhamnoside and chlorogenic acid derived from Smilax china L. EtOAc fraction on xanthine oxidase

Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis in Tongue Squamous Cell Carcinoma by Modulating miR-21/FOXG1 Pathway

Ligand fishing based on bioaffinity ultrafiltration for screening xanthine oxidase inhibitors from citrus plants

Xanthine oxidase inhibition study of isolated secondary metabolites from Dolichandrone spathacea (Bignoniaceae): In vitro and in silico approach

Lignan and Phthalide Derivatives from the Rhizome of Ligusticum chuanxiong ( Rhizoma chuanxiong ) and Evaluation of Their anti -Xanthine Oxidase Activities

Liquiritin alleviates alpha-naphthylisothiocyanate-induced intrahepatic cholestasis through the Sirt1/FXR/Nrf2 pathway

Glycosides and Xanthine Oxidase Inhibitors from Conyza Bonariensis

Inhibitory Effect of Isoliquiritigenin in Niemann-Pick C1-Like 1-Mediated Cholesterol Uptake

Inhibitory Mechanism of Xanthine Oxidase by 6-, 8- and 10-Gingerol: Enzyme Kinetics, Multi-Spectroscopy and Molecular Simulations

Inhibition Of Xanthine And Monoamine Oxidases By Stilbenoids From Veratrum Taliense

Effect of kaffir lime (Cytrus hystrix) leaf extract on xanthine oxidase inhibition

Xanthine Oxidase Inhibition and Anti-LDL Oxidation by Prenylated Isoflavones from Flemingia philippinensis Root

Biotransformation of Liquiritigenin into Characteristic Metabolites by the Gut Microbiota

Pharmacological activities and pharmacokinetics of liquiritin: A review

Anti-lung Cancer, Anti-microbial, Anti-α-glucosidase, Anti-sorbitol Dehydrogenase, and in silico Studies of Wogonoside and Isoliquiritigenin as Natural Compounds

Inhibitory Activity of Quercetin, Rutin, and Hyperoside against Xanthine Oxidase: Kinetics, Fluorescence, and Molecular Docking